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Abstract
Introduction: Calcium-containing (CaC) crystals, including basic calcium phosphate (BCP) and calcium
pyrophosphate dihydrate (CPP), are associated with destructive forms of osteoarthritis (OA). We assessed their
distribution and biochemical and morphologic features in human knee OA cartilage.
Methods: We prospectively included 20 patients who underwent total knee replacement (TKR) for primary OA.
CaC crystal characterization and identification involved Fourier-transform infra-red spectrometry and scanning
electron microscopy of 8 to 10 cartilage zones of each knee, including medial and lateral femoral condyles and
tibial plateaux and the intercondyle zone. Differential expression of genes involved in the mineralization process
between cartilage with and without calcification was assessed in samples from 8 different patients by RT-PCR.
Immunohistochemistry and histology studies were performed in 6 different patients.
Results: Mean (SEM) age and body mass index of patients at the time of TKR was 74.6 (1.7) years and 28.1 (1.6)
kg/m², respectively. Preoperative X-rays showed joint calcifications (chondrocalcinosis) in 4 cases only. The medial
femoro-tibial compartment was the most severely affected in all cases, and mean (SEM) Kellgren-Lawrence score was
3.8 (0.1). All 20 OA cartilages showed CaC crystals. The mineral content represented 7.7% (8.1%) of the cartilage
weight. All patients showed BCP crystals, which were associated with CPP crystals for 8 joints. CaC crystals were
present in all knee joint compartments and in a mean of 4.6 (1.7) of the 8 studied areas. Crystal content was similar
between superficial and deep layers and between medial and femoral compartments. BCP samples showed spherical
structures, typical of biological apatite, and CPP samples showed rod-shaped or cubic structures. The expression of
several genes involved in mineralization, including human homolog of progressive ankylosis, plasma-cell-membrane
glycoprotein 1 and tissue-nonspecific alkaline phosphatase, was upregulated in OA chondrocytes isolated from CaC
crystal-containing cartilages.
Conclusions: CaC crystal deposition is a widespread phenomenon in human OA articular cartilage involving the
entire knee cartilage including macroscopically normal and less weight-bearing zones. Cartilage calcification is
associated with altered expression of genes involved in the mineralisation process.
Introduction
Osteoarthritis (OA) is a whole-joint disease characterized
by cartilage destruction with cartilage mineralization, sub-
chondral bone modifications and mild synovial inflamma-
tion. The two main types of calcium-containing (CaC)
crystals encountered in hyaline and fibrous cartilage
mineralization are calcium pyrophosphate (CPP) and
basic calcium phosphate (BCP) crystals. Cartilage and
meniscus calcification evidenced on conventional radio-
graphs is named chondrocalcinosis [1]. BCP crystals are a
heterogeneous group of CaC crystals that encompass
hydroxyapatite, carbonated apatite (CA), octacalcium
phosphate, amorphous carbonated calcium phosphate
(ACCP), tricalcium phosphate and whitlockite (WH)
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(magnesium-substituted) crystals. Both monoclinic and
triclinic CPP crystals and the different members of BCP
crystals have been found in synovial fluid [2]. The patho-
genic role of CPP and BCP crystal deposition in cartilage
is still unclear and controversial [3,4]. However, growing
clinical and experimental evidence indicates that CaC
crystals may induce real microcrystal stress on synovio-
cytes and chondrocytes, leading to OA lesion worsening
and/or development [5].
Articular calcification is a well-known phenomenon
observed in late-stage OA [6-8]. However, recent find-
ings suggest that cartilage mineralization is a dynamic
process occurring during or prior to OA development.
Scotchford and colleagues detected BCP crystals in 12
cartilage samples from normal femoral heads of patients
undergoing prosthetic replacement due to fracture of
the femoral neck or distal femoral tumor. Transmission
electron microscopy revealed calcifications in juvenile
femoral head cartilage from patients as young as 10
years old and in five patients younger than 25 years old
[9]. Similarly, Mitsuyama and colleagues, in a cadaveric
study of 56 individual donors (mean age 50.3 years,
range 12 to 74 years), showed calcifications in knee car-
tilage of young donors (23 donors <40 years old) and in
normal-to-mildly affected cartilage, with 40% of tibial
cartilage samples and 58% of femoral cartilage samples
showing only grade 1 (macroscopically normal hyaline
appearance) or grade 2 (minimal fibrillation) cartilage
[10]. Moreover, the authors showed that calcification
was diffused in the joint and comparable between
femoral condyles and tibial plateaux. However, they did
not distinguish superficial areas from deep zones, and
the type of CaC crystals was not assessed [10]. Fuerst
and colleagues reported that calcification was constantly
identified in OA cartilage harvested during total knee
replacement and that 40% of the mineralized cartilages
were from patients with only mild OA lesions [6].
Moreover, chondrocytes isolated from OA cartilage
showed differentiation toward a pro-mineralizing hyper-
trophic phenotype, whereas those isolated from normal
cartilage did not [6]. Unfortunately, the authors exam-
ined only the most loaded and destroyed compartment
of the knee joint, namely the medial femoral condyle
cartilage. Sun and colleagues also showed that chondro-
cytes from OA meniscus could differentiate toward a
pro-mineralized phenotype as compared with normal
meniscus chondrocytes [11]. All of these findings sug-
gest that hyaline and fibrous cartilage mineralization is a
dynamic process involving chondrocyte metabolism
dysfunction.
Extracellular inorganic phosphate (Pi) and extracellu-
lar inorganic pyrophosphate (PPi) concentrations are
critical determinants of mineralization. Extracellular Pi
and extracellular PPi are regulated by several proteins.
The extracellular PPi concentration is controlled by
three ectoenzymes: plasma-cell membrane glycoprotein
1 (PC-1)/ectonucleotide pyrophosphatase phosphodies-
terase 1, which hydrolyzes nucleotide triphosphate into
PPi; and AMP, the multipass transmembrane ankylosis
(ANK) transporter; as well as the tissue-nonspecific
alkaline phosphatases (TNAPs), which hydrolyze PPi
into 2-Pi [12]. PPi is a potent inhibitor of apatite crystal
formation, but its excess leads to CPP crystal deposition.
The mRNA expression of these three molecules is
higher in OA than in normal chondrocytes [11,13,14].
Sun and colleagues also showed increased expression of
PC-1 and human ANK (ANKH) genes in chondrocytes
isolated from OA meniscus [11].
We speculated that cartilage mineralization could
affect the whole joint. We assessed the distribution of
these mineral phases in human knee OA cartilage and
their biochemical composition and morphological
aspects, as well as changes in the expression of genes
involved in the mineralization process. We found that
cartilage calcification was a widespread phenomenon
during OA, involving all joint compartments including
nonweight-bearing zones and the whole depth of carti-
lage. Several types of CaC crystals were identified and
the crystals displayed various morphological aspects.
Finally, we observed that ANKH, PC-1 and TNAP
expression was upregulated in chondrocytes isolated
from CaC crystal-containing cartilages. Our results sug-
gest that cartilage mineralization in OA may be asso-
ciated with generalized chondrocyte dysfunction and
changes toward a promineralizing phenotype.
Materials and methods
Patients
Specimens of knee joint cartilage were obtained from 20
prospective patients undergoing total knee replacement
for OA at a single orthopedic department, Lariboisière
hospital, Paris, France. One rheumatologist (CN) col-
lected data on age, sex, body mass index, presence of
genu varum or genu valgum deviation and preoperative
knee plain radiographs (standard anteroposterior and
lateral views) from the orthopedic charts of patients.
Radiographs of the knees were analyzed for calcification
deposition in medial and/or lateral joint spaces to define
chondrocalcinosis. Knee OA radiographic severity was
graded according to the Kellgren-Lawrence scale [15].
Patients with secondary OA (inflammatory disease or
trauma) were excluded. In a second experiment, 14 dif-
ferent patients were included and knee joint cartilage
was collected for histology studies and mRNA isolation.
Cartilage sample preparation
We obtained specimens of femoral condyle and tibial pla-
teau cartilage from both medial and lateral compartments
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(Figure 1A), for a theoretical total of eight samples of car-
tilage zones for each knee. Intercondylar cartilage was
also retrieved when available (n = 9). Specimens were
washed three times in calcium-free phosphate-buffered
saline to avoid contamination by crystals released from
subchondral bone at the time of surgery. Samples of each
femoro-tibial compartment consisted of slices 1 mm
thick, cut with a scalpel tangentially within the superficial
and deep layers of the articular cartilage, as previously
described (Figure 1B) [16]. Cartilage samples were
directly frozen and stored at -20°C for scanning electron
microscopy and Fourier-transform infrared (FT-IR) spec-
troscopy analysis. This protocol preserves the physico-
chemical integrity of the mineral part of cartilage.
Histology and immunohistochemistry staining
Cartilage samples were harvested from six different
patients. For each patient, two adjacent cartilage samples
were collected at the superficial zone of the medial and
lateral femoral condyles and tibial plateaux. One sample
was analyzed by FT-IR spectroscopy to identify the pre-
sence and type of CaC crystals. The second was fixed
with 4% paraformaldehyde (pH 7.4) for 48 hours at 4°C,
and then decalcified with 1% paraformaldehyde-0.2 M
ethylenediamine tetraacetic acid (pH 7.4, 4°C). The spe-
cimens were then dehydrated with increasing concentra-
tions of ethanol, before being embedded in paraffin.
Paraffin sections (5 μm) were deparaffinized in Tissue
Clear (Bayer Diagnostics, Puteaux, France) and rehy-
drated in a graded series of ethanol. Hydrogen peroxide
(3%) was then used to quench endogenous peroxidase,
and sections were incubated overnight in a pH 6.0
citrate buffer at 70°C. Nonspecific sites were blocked for
1 hour using the Impress Kit MP7500 (Vector/Vectas-
tain, Les Ulis, France). Sections were then incubated
overnight in humidified atmosphere at 4°C with primary
polyclonal antibodies for ANK and ectonucleotide pyro-
phosphatase phosphodiesterase 1 (ENPP-1; 1:200) [17].
After two washes in phosphate-buffered saline, horse-
radish peroxidase-conjugated secondary antibody (goat
Figure 1 Knee joint specimen obtained during total knee replacement and schematic representation of sample collection protocol. (A)
Specimens included femoral condyle and tibial plateau cartilage from both medial and lateral compartments, as previously described [12]. (B)
Cartilage areas were: 1, medial condyle; 2, lateral condyle; 3, medial tibial plateau; 4, lateral tibial plateau; S, superficial layer; D, deep layer (two
samples each of S and D); E, intercondyle cartilage was harvested if available. A maximum of 10 articular cartilage slices could be harvested from
each knee joint.
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anti-rabbit IgG, Vectastain ABC kit; Novocastra, Le Per-
ray en Yvelines, France) was applied for 30 minutes at
room temperature. The signal was developed with use
of permanent AEC Chromogen (Diagomics, Blagnac,
France). Nuclei were counterstained with hematoxylin,
and slices were mounted in Eukitt (CML, Nemours,
France). Sections incubated without primary antibody
were controls.
For OA lesion analysis, sections were stained in 0.5%
Safranin-O and rinsed with distilled water. OA lesion
and immunohistochemistry (IHC) scoring was per-
formed independently by two authors (H-KE and DC)
with blinding to FT-IR spectroscopy results and other
cartilage sample characteristics. Positive cells were
counted on the same defined area and expressed as a
percentage of the total cell count.
RNA isolation and quantitative real-time reverse
transcriptase-polymerase chain reaction
Chondrocytes were isolated from eight different tibial
plateau samples of cartilage by enzymatic digestion (type
2 collagenase; Sigma, Saint-Quentin Fallavier, France)
and placed into culture dishes for 30 minutes. Chondro-
cytes were then collected and the material that had
deposited on the culture dish was harvested and centri-
fuged at 10,000 rpm for 10 minutes. The supernatant
was discarded and pellets were dried and analyzed by
FT-IR spectroscopy to detect the presence of CaC.
Chondrocyte RNA was extracted using TRIzol (Roche,
Paris, France). RNA was reverse transcribed into
cDNAusing a High Capacity cDNA Reverse Transcrip-
tion kit (Applied Biosystems, Barcelona, Spain), and
then the cDNA product was amplified by polymerase
chain reaction. The mRNA levels for ENPP1 (PC-1),
ANKH, TNAP, solute carrier family 20 (SLC20A1)
(Pit1), 5’-nucleotidase (ecto) (NT5E) (CD73) and riboso-
mal protein S29 were determined using the double
strand-specific iTaq SYBR system (BioRad, Marnes-la-
Coquette, France). All reactions involved the following
thermal profile: 50°C for 2 minutes, denaturation at 95°
C for 10 minutes; and then 40 cycles of denaturation at
95°C for 15 seconds, and annealing and extension at 60°
C for 1 minute (data collection was performed at the
end of each annealing/extension step) (StepOne Plus;
Applied Biosystems). The third step ensures the specifi-
city of the amplicons by measuring their melting tem-
perature. Data analysis involved use of StepOne 2.1
(Applied Biosystems). Results were calculated by the 2
−ΔΔCt method.
The primer sequences were: ribosomal protein S29
(housekeeping gene), sense 5’-GGGTCACCAG-
CAGCTCGAGA-3’ and anti-sense 5’-CAGACACGA-
CAAGAGCGAGA-3’; ANKH, sense 5’-TGCTGTG
TATCGTGCTTTCG-3’ and anti-sense 5’-GAGTGAC
AGAGCCATGCAGA-3’; ENPP1 PC-1, sense 5’-
TGGACCAGTCAGCAGTGAAG-3’ and anti-sense
5’-TCAGGCATCTGTGCAAGTTC-3’: TNAP, sense
5’-GCAGTGAAGGGCTTCTTGTC-3’ and anti-sense 5’-
CCACGTCTTCACATTTGGTG-3’; SLC20A1 (Pit1),
sense 5’-CATGGTGGCAATGACGTAAG-3’ and anti-
sense 5’-TTGGTGTTGCCACTTTTGAA-3’; and NT5E
(CD73), sense 5’-TTTTGCACACCAACGACGTG-3’
and anti-sense 5’-GAACCTTGGTGAAGAGCCGA-3’.
Fourier-transform infrared spectroscopy
The mineral phase was evaluated using a FT-IR Brucker
Vector 22 spectrometer (Brucker Spectrospin, Wissem-
bourg, France), with analysis by the KBr pellet method
[18]. The ratio of the amount of sample mixed with the
KBr was 1%. Data were collected in the absorption
mode between 4,000 and 400/cm, with resolution 4/cm.
The absorption bands of Ca2+ biological reference com-
pounds, namely CA, ACCP and CPP, are well assigned.
For CA, the ν1 and ν3 P-O stretching vibration modes
are measured at 960 to 962 and 1,035 to 1,045/cm,
respectively, whereas the O-P-O ν4 bending mode cor-
responds to the doublet at 602 to 563/cm. The bands at
3,570 and 633/cm, corresponding to the stretching and
vibrational modes, respectively, of the OH- groups, char-
acteristic of hydroxyapatite, are absent for CA. The dis-
appearance of the CA shoulder in the ν3 absorption
band determines the presence of the ACCP compound.
Regarding triclinic CPP, the O-P-O bending is recorded
at 535 and 508/cm. The P-O stretching vibrations corre-
spond to absorption at 923 and 991/cm, and the asym-
metric stretching vibrations correspond to absorption at
1,037 and 1,089/cm.
Scanning electron microscopy
A Zeiss SUPRA55-VP (Goettingen, Germany)field emis-
sion scanning electron microscope was used for micro-
structure observation. This field-effect gun microscope
operates at 0.5 to 30 kV. High-resolution observations
were obtained by two secondary electron detectors: in-
lens SE and Everhart-Thornley SE detectors. To main-
tain the integrity of the specimens, measurements were
performed at low voltage (approximately 2 kV) without
the usual deposits of carbon at the surface of the sam-
ple. Prepared specimens were thawed, air dried and
directly deposited on the sample holder.
Statistical analysis
Data analysis involved using Systat 9 (SPSS Inc., Chi-
cago, IL, USA). Quantitative variables are described with
mean (standard error of the mean), unless indicated,
and qualitative variables with number (percentage).
Nonparametric tests were used because a normal distri-
bution could not be demonstrated for all variables.
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Comparisons between groups involved the Fisher exact
test for qualitative variables and the Mann-Whitney U
test for quantitative data. P < 0.05 was considered statis-
tically significant.
Ethical considerations
All samples and experiments were collected and made
in France. According to the French Ethical law on
human research (L.12111-2 to L.1211-7, L.1211-2 and
L.1245.2), informed consent and ethical approval were
not necessary because tissues were surgical waste from
routine joint replacement surgery and clinical data were
anonymously treated. The investigation conformed to
the principles of the Declaration of Helsinki.
Results
Demographic and clinical data
We included 20 OA patients (17 females). The mean
(standard deviation) age and body mass index of patients
at the time of total knee replacement was 74.6 (1.7) years
(range 58 to 84 years) and 28.1 (1.6) kg/m2, respectively
(Table 1). Preoperative plain radiographs (n = 18)
detected unicompartmental, bicompartmental, or tricom-
partmental knee OA in two, eight, and eight patients,
respectively. In all cases, OA was most severe in the med-
ial femoro-tibial compartment, with a mean Kellgren-
Lawrence score of 3.8 (0.1).
Calcium-containing crystal prevalence and distribution
in knee osteoarthritis
Knee joint radiographs available for 18 of 20 patients
showed calcification in the medial and/or lateral joint
spaces in four (22.2%) cases, whereas FT-IR spectroscopy
detected CaC crystals in specimens for all 20 patients
(Figure 2A). Cartilage calcification was widespread.
Among the eight assessed cartilage areas, CaC crystals
were detected in one to three, three to six and six to
eight areas for four (20%), 10 (50%) and six (30%)
patients, respectively (Figure 2B). CaC crystal prevalence
was similar between lateral and medial femoro-tibial
compartments. In total, 90% and 85% of superficial and
deep cartilage layers, respectively, contained CaC crystals
(not statistically significant). CaC crystal prevalence ran-
ged from 45% in the deep layer of the medial femoral
condyle to 70% in the superficial layer of the medial
femoral condyle, with no significant difference between
superficial and deep areas (Figure 2C). Interestingly, CaC
crystals were also detected in six of nine (66.6%) available
intercondyle cartilage samples (Figure 2C).
The overall mean percentage of cartilage mineral con-
tent was higher in the lateral femoro-tibial than medial
femoro-tibial compartment (7.3% (1.5) vs. 5.2% (1.5), P =
0.03), with no difference between the deep and superficial
cartilage layers and different cartilage areas (Figure 2D).
Calcium-containing crystal biochemical composition and
morphological aspects
Among 141 cartilage samples from 20 OA patients, FT-
IR spectroscopy detected CaC in 63.8% (90/141) and
revealed four distinct CaC crystal spectra: CA crystals in
71 samples, CPP crystals in 20 samples from eight
patients, ACCP crystals in three samples from three
patients, and WH crystals in four samples from the
same patient (Figure 3A). CA crystals were the most fre-
quently identified CaC crystal type and were detected in
all OA knees (Figure 3B). They were the only crystal
type in nine (45%) cases but were associated with CPP,
ACCP and WH crystals in seven (35%) cases, three
(15%) cases and one (5%) case, respectively, at the joint
level. One patient had three types of calcium crystals,
including CA, CPP and ACCP crystals. Remarkably, at
the sample level (n = 141) CPP crystals were concomi-
tantly detected in 16 of the 70 (22.8%) samples not con-
taining CA crystals but in only four of the 71 (5.6%)
samples containing CA crystals (P = 0.003) (Table 2).
This difference was not found for the two other types of
CaC crystals: ACCP and WH.
Among CaC crystals, CA crystals had a more diffuse
spatial distribution and were identified in at least three of
eight areas for 13 (65%) patients, whereas CPP, ACCP
and WH crystals involved fewer than three areas when
detected. The mean (standard error of the mean) overall
mineral content of cartilage in knee joints was 7.7% (1.5).
CA crystals were the most abundant CaC crystals in the
knee OA joint as compared with CPP, ACCP and WH
crystals (4.5% (0.6) vs. 3.1% (1.8), 0.3% (0.2), and 0.1%
(0.1), respectively, P < 0.001) (Figure 3C). The amount of
the four types of CaC was similar between medial and
Table 1 Demographic, clinical, and osteoarthritis features
for 20 patients undergoing total knee replacement
Characteristic
Age (years) 74.6 (1.7)
Male gender 3/20 (15)
Body mass index (kg/m2) 28.1 (1.6)
Affected knee left/right 12/8
Genu varum 15/18 (83.3)
Kellgren-Lawrence grade 3.8 (0.1)
Grade 3 5/18 (22.2)
Grade 4 14/18 (77.8)
Unicompartmental osteoarthritis 2/18 (11.1)
Bicompartmental osteoarthritis 8/18 (38.9)
Tricompartmental osteoarthritis 8/18 (44.4)
Osteoarthritis mainly affecting the medial femoro-tibial
compartment
18/18 (100)
Data presented as number of patients for whom data are available (%) or
mean (standard deviation).
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lateral femoro-tibial compartments and between superfi-
cial and deep cartilage layers (Figure 3C).
Scanning electron microscopy revealed two distinct
morphological patterns according to CaC crystal bio-
chemical composition. From a physico-chemical point of
view, we used the terms ‘nanocrystals’ and ‘crystallites’
according to Van Meerssche and Feneau-Dupont [19] to
define the structural hierarchy of these mineral concre-
ments. Crystallites (measuring typically some tens
of micrometers) are made of a collection of nanocrys-
tals (measuring typically some tens or hundreds of
nanometers) [19]. For CA crystallites, we found the same
morphologic features as found in urinary calculi [20],
resulting in an agglomeration of nanometer-scale apatite
crystals and proteins (Figure 4B, C). Some of these struc-
tures were located near structure sets suggestive of chon-
drons, containing apatite crystallite deposits. For CPP
crystals, scanning electron microscopy revealed typical
rod-shaped crystallites of different sizes and shapes found
widespread at the cartilage sample surface (Figure 4C).
Some of these crystallites showed a cubic morphologic
pattern.
Figure 2 Fourier-transform infrared spectroscopy of prevalence and localization of calcium-containing crystals in osteoarthritic knee
articular cartilage. (A) Data on preoperative knee joint radiographs (standard anteroposterior and lateral views) were retrieved from clinical
charts for 18 of 20 included patients and assessed by one rheumatologist for presence of mineralization in the lateral and/or medial joint spaces
to define chondrocalcinosis (first column) After surgery, specimens were harvested and analyzed by Fourier-transform infrared spectroscopy
(FT-IR) to assess the presence and type of calcium-containing (CaC) crystals (second column). (B) FT-IR spectroscopy of cartilage samples
harvested from the eight to 10 joint areas defined in Figure 1 from all 20 patients to determine the number of areas affected by calcification. n,
number of patients. (C) Prevalence of calcifications and proportion of mineral content (D) as determined by FT-IR spectroscopy. Data are mean
± standard error of the mean. ED, intercondyle deep; ES, intercondyle superficial; IntC, intercondyle; LFT, lateral femoro-tibial compartment; MFT,
medial femoro-tibial compartment; Surf, superficial.
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Clinical and radiological correlates with Ca2+ crystal
deposits
The CaC crystal amount in OA knee joints was not asso-
ciated with age or body mass index. Mean cartilage CA
crystal content in the whole joint was significantly higher
in joints with chondrocalcinosis than without chondrocal-
cinosis as revealed by X-ray scans (6.0% (1.6) vs. 3.8%
(2.0), P < 0.05). Conversely, joints with and without chon-
drocalcinosis did not differ in cartilage CPP or ACCP crys-
tal content, whatever the location (whole joint, lateral or
Figure 3 Fourier-transform infrared spectroscopy of biochemical composition of calcium-containing crystals in osteoarthritic knee
articular cartilage. (A) Four distinct types of Fourier-transform infrared spectroscopy (FT-IR) spectra in osteoarthritis articular cartilage:
carbonated apatite (CA) crystals, calcium pyrophosphate (CPP) crystals, amorphous Ca2+ carbonated phosphate (ACCP) crystals and whitlockite
(WH) crystals. (B) Joint-level prevalence of calcium-containing (CaC) crystal types. n, number of patients. (C) Content (%) of crystal type in
samples according to joint compartment. Data are mean ± standard error of the mean. LFT, lateral femoro-tibial compartment; MFT, medial
femoro-tibial compartment
Table 2 Other calcium-containing crystal types in same cartilage area according to presence/absence of carbonated
apatite crystals
Crystal Samples without CA crystals (n = 70) Samples with CA crystals (n = 71) P value
CPP 16 (22.8) 4 (5.6) 0.003
ACCP 2 (2.9) 1 (1.4) 0.551
WH 1 (1.4) 3 (4.3) 0.317
Data presented as number (%). ACCP, amorphous carbonated calcium phosphate; CA, carbonated apatite; CPP, calcium pyrophosphate crystals; WH, whitlockite.
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medial compartments) or the number of affected areas.
These features were similar for patients with Kellgren-
Lawrence grade 4 and grade < 4.
Cartilage calcification is associated with increased
expression of genes involved in mineralization process
To assess the mechanisms by which the widespread cal-
cification phenomenon in OA cartilage occurred, we
performed IHC and analyzed the expression of several
genes involved in the metabolism of PPi and Pi, including
ENPP-1 (PC-1), ANKH, TNAP, SCL20A1 (Pit1) and
NT5E (CD73). OA lesions were assessed by Safranin-O
staining of 22 cartilage samples obtained from six differ-
ent patients according to Osteoarthritis Research Society
International recommendations [21]. Medial and lateral
femoral condyles and tibial plateaux were analyzed. Eight
of 22 (36.3%) samples did not display any OA lesions and
14 of 22 (63.6%) displayed grade 2 or grade 3 OA lesions
(Figure 5A). The absence and mild OA lesions were due
to the samples being harvested in zones where the carti-
lage was still visible macroscopically. This sampling was
required for FT-IR spectroscopy analysis. CA crystals
were detected in three of the eight (37.5%) cartilage sam-
ples without OA lesions and in seven of the 14 (50%)
with OA lesions as determined by Safranin-O staining.
The ratio of chondrocytes with positive staining for PC-1
or ANKH expression was similar between cartilage sam-
ples with and without CA crystals (77.2% (5.0) vs. 67.9%
(6.2) for ANKH (P = 0.21), and 78.5% (5.6) vs. 68.3%
(7.7) for PC-1 (P = 0.25), respectively) (Figure 5A, B).
To assess the whole tibial cartilage and not just a lim-
ited cartilage area, we analyzed the expression of genes
involved in PPi and Pi metabolism and assessed their
association with presence of CaC crystals. We isolated
chondrocyte mRNA from the tibial plateau cartilage for
eight new patients. Six samples contained calcification
and two did not. CPP crystals were identified in 3/6
samples, CA crystals in 2/6 and both CPP and CA crys-
tals in 1/6. The two samples without calcification were
used as a control and the mRNA expression of the dif-
ferent proteins was relative to expression in these two
samples. In cartilage samples containing CPP crystals,
ENPP1 (PC-1) and ANKH mRNA levels were signifi-
cantly higher, by 2.6-fold (P < 0.01) and 3.7-fold (P =
0.05), respectively, than in cartilage without CPP crystals
(Table 3), with no significant difference for levels of
TNAP, SLCA201 (Pit1) and NT5E (CD73). Similarly,
ENPP-1, TNAP and ANKH mRNA levels were higher in
cartilage with CA crystals than in cartilage without CA
crystals (1.81-fold, 5.73-fold and 2.24-fold, respectively),
with no difference in levels of SLC20A1 (Pit1) and
NT5E (CD73).
Discussion
Mineralization of hyaline cartilage and fibrocartilage is a
common phenomenon of end-stage OA and has been
associated with OA progression and cartilage destruc-
tion [6,11]. We confirmed the high frequency of carti-
lage mineralization in knee articular cartilage harvested
during total knee replacement. Furthermore, cartilage
mineralization was widespread in OA and occurred with
similar frequency in all articular cartilage compartments,
Figure 4 Scanning electron microscopy of morphological
aspects of calcium-containing crystals in osteoarthritic knee
articular cartilage. Representative images of crystals in cartilage.
(A) Cartilage without calcification. (×755 magnification). (B)
Agglomeration of several apatite crystallites localized in structure
sets suggestive of chondrons and an agglomeration of apatite
crystallites (×755 magnification). (C) Typical rod-shaped calcium
pyrophosphate crystals and cubic morphologic feature of some
crystallites (×2,999 magnification).
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including nonweight-bearing zones and those free of
lesions (such as intercondyle cartilage). In addition, the
presence of CaC crystals was associated with a signifi-
cant upregulation of the expression of genes, including
ENPP1 (PC-1) and ANKH, which are involved in Pi and
PPi homeostasis.
In a cadaveric study of 106 knees, Mitsuyama and
colleagues showed that calcification was widespread in
knee cartilages and involved both femoral condyles and
tibial plateaus [10]. Similarly, in an anatomic, radio-
graphic and magnetic resonance imaging study of 10
cadaveric knees of older subjects, Abreu and colleagues
found diffuse calcifications involving menisci and hya-
line cartilage but also other joint tissues such as cruci-
ate ligaments, popliteus tendon and joint capsule in
40% of the joints [22]. Finally, in a cadaveric study of
68 knees, computed tomography frequently detected
calcifications in menisci, femoro-tibial cartilages as well
as proximal tibio-fibular cartilages [23]. However, all of
these studies only assessed the presence of calcifica-
tions without characterizing the type of CaC crystals.
Here, we used FT-IR spectroscopy and scanning elec-
tron microscopy to describe for the first time the dis-
tribution and type of CaC crystals in the whole knee
joint, systematically analyzing eight to 10 cartilage
areas for each knee, according to a standardized sam-
ple-harvesting protocol.
Although CA crystals were the main mineral detected,
cartilage mineralization consisted of several types of
CaC crystals with different physico-chemical properties
and different shapes. As in Fuerst and colleagues’ study,
BCP crystals were detected in all samples whereas CPP
crystals were found in only 40% [6]. However, the
authors only analyzed the medial femoral condyle and
Figure 5 Human plasma-cell-membrane glycoprotein 1 and homolog of progressive ankylosis expression in cartilage with/without
calcification. Examples of normal cartilage without calcification and mildly degraded cartilage containing carbonated apatite crystals. (A)
Safranin-O staining and immunohistochemistry (IHC) staining of human plasma-cell-membrane glycoprotein 1 (PC-1) and homolog of
progressive ankylosis (ANKH). (B) Quantitative expression of PC-1 and ANK according to the presence or not of calcium-containing crystals.
Immunohistochemistry analysis was performed by two researchers who were blinded to Fourier-transform infrared spectroscopy results. The
number of chondrocytes expressing PC-1 or ANKH is relative to the total number of chondrocytes. CC = calcium-containing crystals.
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did not differentiate superficial from deep zone cartilage.
We rarely found CPP and BCP crystals in the same
sample or zone, which suggests a tight balance between
Pi and PPi metabolism. Indeed, excess PPi can lead to
CPP crystal deposition, whereas low levels favor BCP
crystal formation [24]. However, the observation of both
CaC crystal types in some samples suggests that the Pi/
PPi balance could change during OA disease.
The mechanisms of articular cartilage calcification in
normal and OA cartilages are unknown. Several factors
identified include genetics, aging, extracellular matrix
modifications, imbalance between inhibitors and promi-
neralizing factors, dysregulation of PPi and Pi metabo-
lism, and chondrocyte phenotype alterations such as
hypertrophic differentiation and apoptosis [25,26]. Sev-
eral studies have shown that chondrocytes isolated from
OA cartilage were prone to induce calcifications in
vitro. The phenotype of these chondrocytes differed
from that of chondrocytes isolated from normal carti-
lage. They were hypertrophic, expressed type X collagen
and/or had upregulated expression of several genes
involved in the mineralization process including ENPP-1
and ANKH [6,11,27]. We also observed an increase in
mRNA expression of ENPP-1 (PC-1) and ANKH in
chondrocytes from tibial cartilage containing CPP crys-
tals as compared with cartilage without CPP crystals.
However, IHC revealed no differences at the protein
level. This result could be explained by the mild degra-
dation of the cartilage samples used for IHC assessment.
Further studies assessing more severe OA cartilage are
required. Hirose and colleagues found a similar expres-
sion of PC-1 and ANK in OA cartilage with and without
CPP crystal deposition [28]. However, extracellular PPi
production was greater in chondrocytes from CPP crys-
tal-containing cartilage than OA cartilage without crys-
tals. These proteins may have both post-transcriptional
and post-translational regulation mechanisms, but other
proteins may be involved in the mineralization process.
Recently, CD73 protein was found to have a potent inhi-
bitor role in vascular and peri-articular mineralization
[29]. St Hilaire and colleagues showed nonfunctional
mutations in NT5E in members of three families with
symptomatic arterial and joint calcifications. This gene
encodes CD73, which participates in the extracellular
pathway that converts AMP to adenosine. PC-1 hydro-
lyzes ATP into PPi and AMP, which is then converted
to adenosine and Pi by CD73. Adenosine inhibits TNAP
activity. CD73 deficiency therefore leads to increased
TNAP activity, thus enhancing PPi degradation and Pi
accumulation, both of which favor mineralization [29].
Whether the same phenomenon exists in OA cartilage
needs to be further assessed. We observed that the
NT5E mRNA expression was similar in chondrocytes
isolated from cartilage with and without calcification.
The protein level was not assessed because no efficient
antibody is available.
In this study we did not show any association of
radiographic OA grade or age and cartilage calcification,
probably because our study was underpowered with its
small patient sample and because our samples were
mostly end-stage OA. However, Fuerst and colleagues
showed that a radiographic Kellgren-Lawrence score
and histological lesions correlated with cartilage calcifi-
cation [6]. Moreover, Nalbant and colleagues reported
that the presence of CaC crystals in OA synovial fluid
was a predictor of OA progression [30]. Recently, we
showed that intra-articular injection of BCP crystals into
mouse knee induced cartilage degradation along with
synovial inflammation [31]. Altogether, these data indi-
cate that cartilage calcification may represent a signifi-
cant pathogenic process during OA. Several issues
remain to be addressed in CaC crystal-associated OA
management, including the development of diagnostic
tools to conveniently detect BCP crystals in synovial
fluid and imaging techniques to detect CaC crystals in
OA joints in vivo such as high-resolution computed
tomography or ultrasonography, which could be used
on a routine basis.
Conclusions
Our results suggest that cartilage mineralization is a
widespread and constant process in the OA joint,
Table 3 Genes differentially expressed by cartilage calcification in samples from six patients with osteoarthritis
Gene name Gene ID Differential gene expression (fold-change) compared with OA cartilage without calcification
CPP crystals CA crystals CPP + CA
OA1 OA2 OA3 Mean OA4 OA5 Mean OA6
ENPP1 (PC-1) MIM 173335 2.98 2.29 2.59 2.62** 2.54 1.09 1.81 (NS) 2.5
ANKH MIM 605145 3.54 2.67 4.94 3.72* 2.66 1.83 2.24 (NS) 1.82
TNAP MIM 171760 2.20 7.74 56.10 22.01 (NS) 9.26 2.20 5.73 (NS) 2.17
SLC20A1 (Pit1) MIM 137570 1.55 1.34 0.82 1.24 (NS) 1.82 1.63 1.72 (NS) 1.19
NT5E (CD73) MIM 129190 0.82 1.27 0.78 0.96 (NS) 2.00 0.57 1.28 (NS) 1.59
ANKH, ankylosis progressive homolog; CA, carbonated apatite; CPP, calcium pyrophosphate; ENPP1, ectonucleotide pyrophosphatase 1; NS, not significant; NT5E,
5’-nucleotidase (ecto) or CD73 protein; OA, osteoarthritis; SLC20A1, solute carrier family 20 (phosphate transporter), member 1 or Pit1; TNAP, tissue nonspecific
alkaline phosphatase. **P < 0.01 (vs. samples without calcification), *P < 0.05 (vs. samples without calcification).
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occurring even in nonweight-bearing intercondyle carti-
lage. Mineralization involved several compartments and
several types of CaC crystals. This process is associated
with an increase in the expression of genes involved in
Pi and PPi homeostasis, which suggests a switch toward
a promineralizing chondrocyte phenotype in OA. Mole-
cular and biomechanical mechanisms controlling the
articular chondrocyte fate toward a promineralizing phe-
notype and driving cartilage mineralization in OA
remain largely undetermined. Further investigation with
larger samples is required to address these questions
and could lead to new specific therapies in OA targeting
the associated mineralization process.
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